BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31107749)

  • 1. Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
    Osborne JR; Kondraciuk JD; Rice SL; Zhou X; Knezevic A; Spratt DE; Sabra M; Larson SM; Grewal RK
    Clin Nucl Med; 2019 Jul; 44(7):544-549. PubMed ID: 31107749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
    Kondraciuk JD; Rice SL; Zhou X; Gharzeddine K; Knezevic A; Spratt DE; Sabra M; Larson SM; Grewal RK; Osborne JR
    Clin Nucl Med; 2019 Aug; 44(8):e465-e471. PubMed ID: 31274625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis After Brain Metastasis from Differentiated Thyroid Carcinoma.
    Saito F; Uruno T; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
    World J Surg; 2016 Mar; 40(3):574-81. PubMed ID: 26762631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
    Choi J; Kim JW; Keum YS; Lee IJ
    PLoS One; 2016; 11(4):e0154739. PubMed ID: 27128487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metastases from thyroid carcinoma: a retrospective study of 21 patients.
    Henriques de Figueiredo B; Godbert Y; Soubeyran I; Carrat X; Lagarde P; Cazeau AL; Italiano A; Sargos P; Kantor G; Loiseau H; Bonichon F
    Thyroid; 2014 Feb; 24(2):270-6. PubMed ID: 23734630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
    Lee J; Soh EY
    Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
    Wassermann J; Bernier MO; Spano JP; Lepoutre-Lussey C; Buffet C; Simon JM; Ménégaux F; Tissier F; Leban M; Leenhardt L
    Oncologist; 2016 Jan; 21(1):50-8. PubMed ID: 26675742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
    Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
    J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of brain metastasis from esophageal cancer.
    Welch G; Ross HJ; Patel NP; Jaroszewski DE; Fleischer DE; Rule WG; Paripati HR; Ramirez FC; Ashman JB
    Dis Esophagus; 2017 Sep; 30(9):1-6. PubMed ID: 28859365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients.
    Hsiao SH; Lin HC; Chou YT; Lin SE; Kuo CC; Yu MC; Chung CL
    Lung Cancer; 2013 Sep; 81(3):455-461. PubMed ID: 23871711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis.
    da Costa AABA; Dos Santos ES; Cotrim DP; Pandolfi NC; Cesca MG; Mantoan H; Sanches SM; Ribeiro ARG; de Brot L; Bonvolim G; Sanematsu PI; de Souza RP; Maya JML; de Souza Castro F; da Nogueira Silveira Lima JP; Chen MJ; Guimarães APG; Baiocchi G
    BMC Cancer; 2019 Dec; 19(1):1194. PubMed ID: 31805898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?
    Han G; Bi J; Tan W; Wei X; Wang X; Ying X; Guo X; Zhou X; Hu D; Zhen W
    Oncotarget; 2016 Aug; 7(35):56998-57010. PubMed ID: 27486770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
    Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
    Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
    Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
    J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic site discriminates survival benefit of primary tumor surgery for differentiated thyroid cancer with distant metastases: A real-world observational study.
    Ding W; Ruan G; Zhu J; Tu C; Li Z
    Medicine (Baltimore); 2020 Nov; 99(48):e23132. PubMed ID: 33235073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
    Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
    BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prognosis for patients with differentiated thyroid carcinoma bone metastases.
    Wang S; Luo J; Zhong Z; Qi X; Liu T; Qin R; Zhao Z; Xi Y; Sun R; Wu Y; Sun C
    Transl Cancer Res; 2020 Feb; 9(2):972-982. PubMed ID: 35117442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.